PFSCM Annual Report 2023 – celebrating a year of growth and diversification

by | Apr 29, 2024

The Partnership for Supply Chain Management (PFSCM) enjoyed another successful year in 2023.

We expanded our service offering to include even more product categories, elevated our operations with new certifications, and partnered with our clients, suppliers, and service providers to deliver complex solutions in challenging environments.

PFSCM continued to deliver a full range of supply chain services to its clients using a category management approach. This starts with a strategic category assessment that aligns with a client’s needs and is then translated into operational guidelines to effectively deliver health products and services based on the particular characteristics of that category and its products. This allows us to provide fit-for-purpose services, whether it is purchasing and delivering pharmaceuticals and rapid diagnostic tests, establishing and supporting all-inclusive pricing agreements for analyzers, or delivering complex project-based products such as large-scale medical waste incinerators, CT scanners, or next-generation sequencing machines and reagents.

In the past year, we have also expanded our product category offerings to include health products for antimicrobial resistance and harm reduction programs.

Highlights from 2023 include:

  • Assisted our clients roll out more than 120 tuberculosis (TB) analyzers in Nigeria, more than 80 x-ray machines in Pakistan, 76 autoclaves in Zimbabwe, 125 portable ultrasound machines in Tanzania, and multiple CT scanners in Mozambique.
  • Procured more than $398 million worth of health products and delivered 2,602 shipments to 84 countries.
  • Worked closely with our clients, suppliers, and freight forwarders to ensure health products continue to be delivered to Palestine, Ukraine, Niger, Yemen, Syria, and the Democratic Republic of the Congo, among other turbulent countries.
  • Continued to procure and deliver pharmaceuticals like antiretrovirals, dietary products like vitamins, rapid test kits for HIV, malaria, and TB, contraceptives, medical and imaging equipment, and a broad range of analyzers including molecular, CD4 count, hematology, microbiology, chemistry, and genomic analyzers as well as the reagents and consumables to support these products.

In our continuing pursuit of operational excellence, we garnered several licenses and certifications in 2023. We earned our triennial ISO 9001:2015 Quality Management System (QMS) recertification, passed a Quality Assurance audit completed by humanitarian development nonprofit FHI360, and received a Wholesale Distributor Authorization permit from the Ministry of Health of the Netherlands.

In 2023, we continued to make good progress toward our sustainability goals. We relocated to a new, larger, more sustainable office in Woerden, Netherlands. We published our Sustainability Report for 2022, released our Sustainability Strategy plan for 2023/24, joined the WHO-led Alliance for Action on Climate Change and Health (ATACH), and were recognized by an accredited global auditing firm for aligning with the ISO 20400:2017 guideline for Sustainable Procurement.

Our work and success are based on the efforts of our committed staff and collaborative, supportive relationships with our clients, suppliers, and service providers. We look forward to continued success in the coming year in delivering on our mission and meeting our clients’ needs in the everchanging global health landscape.

Read our condensed annual report here.


PFSCM Director, Edward Wilson